Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects and Mechanisms of Fisetin Against Ischemia-Reperfusion Injuries: A Systematic Review Publisher Pubmed



Adeli OA1, 2 ; Heidarisoureshjani S3 ; Rostamian S4 ; Azadegandehkordi Z5 ; Khaghani A6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pathology, Lorestan University of Medical Sciences, Khorramabad, Iran
  2. 2. Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  3. 3. Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  4. 4. Department of Medicine, Harvard Medical School, Boston, MA, United States
  5. 5. Oriented Nursing Midwifery Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  6. 6. Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Current Pharmaceutical Biotechnology Published:2024


Abstract

Background: Ischemia-reperfusion injury (IRI) is a well-known ailment that can disturb organ function. Objectives: This systematic review study investigated fisetin's effects and possible mechanisms in attenuating myocardial, cerebral, renal, and hepatic IRIs. Methods: This systematic review included studies earlier than Sep 2023 by following the PRISMA statement 2020. After determining inclusion and exclusion criteria and related keywords, bibliographic databases, such as Cochrane Library, PubMed, Web of Science, Embase, and Scopus databases, were used to search the relevant studies. Studies were imported in End-Note X8, and the primary information was recorded in Excel. Results: Fisetin reduced reactive oxygen species (ROS) generation and upregulated antioxidant enzymes, such as superoxide dismutase (SOD), glutathione (GSH), catalase (CAT), and glutathione peroxidase (GPx), in ischemic tissues. Moreover, fisetin can attenuate oxidative stress by activating phosphoinositide-3-kinase–protein kinase B/Akt (PI3K/Akt) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways. Fisetin has been indicated to prevent the activation of several pro-inflammatory signaling pathways, including NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) and MAPKs (Mitogen-activated protein kinases). It also inhibits the production of pro-inflammatory cytokines and enzymes like tumor necrosis factor-a (TNF-α), inducible-NO synthase (iNOS), cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), interleukin-1β (IL-1β), IL-1, and IL-6. Fisetin attenuates IRI by improving mito-chondrial function, anti-apoptotic effects, promoting autophagy, and preserving tissues from histological changes induced by IRIs. Conclusion: Fisetin, by antioxidant, anti-inflammatory, mitochondrial protection, promoting autophagy, and anti-apoptotic properties, can reduce cell injury due to myocardial, cerebral renal, and hepatic IRIs without any significant side effects. © 2024 Bentham Science Publishers.
Other Related Docs
17. Has Vitamin E Any Shreds of Evidence in Cisplatin-Induced Toxicity, Journal of Biochemical and Molecular Toxicology (2019)
30. Carotenoids As Potential Antioxidant Agents in Stroke Prevention: A Systematic Review, International Journal of Preventive Medicine (2017)
44. Astaxanthin Prevents Nephrotoxicity Through Nrf2/Ho-1 Pathway, Canadian Journal of Physiology and Pharmacology (2024)
50. Reviewing Blood Serum Uric Acid in Patients With Stroke, Journal of Isfahan Medical School (2011)